Bionanotechnology News

RSS

Tekmira Comments on Alnylam’s Recently Presented Clinical Data of ALN-VSP Candidate

Tekmira Comments on Alnylam’s Recently Presented Clinical Data of ALN-VSP Candidate

Tekmira Pharmaceuticals Corporation a leading developer of RNA interference (RNAi) therapeutics, today provided the following comment on Alnylam Pharmaceuticals, Inc.'s recently presented data from a Phase 1 human clinical trial for ALN-VSP showing that analysis of human tissue samples demonstrated proof of RNAi in man.

11 Jan 2011

Researcher Works to Identify Variety of Biomarkers for Early Cancer Detection

Researcher Works to Identify Variety of Biomarkers for Early Cancer Detection

Using biological samples taken from patients and state-of-the-art biochemical techniques, a Florida State University researcher is working to identify a variety of "biomarkers" that might provide earlier warnings of the presence of breast and prostate cancers.

11 Jan 2011

Silicon Microdevices May Help to Screen Metastatic Breast Cancer Cells

Silicon Microdevices May Help to Screen Metastatic Breast Cancer Cells

Research by engineers and cancer biologists at Virginia Tech indicate that using specific silicon microdevices might provide a new way to screen breast cancer cells’ ability to metastasize.

10 Jan 2011

Global Nanobiotechnology Products Market Estimated to Reach $29.7 Billion by 2015

Global Nanobiotechnology Products Market Estimated to Reach $29.7 Billion by 2015

Nanotechnology is coming of age as a materials platform in multiple industries including the biotechnology industry.

7 Jan 2011

New Coating Strategy Simplifies DNA Microarray Technique

Simple and universal DNA immobilization on surfaces with synthetical mussel polymer. Mussels are true masters of adhesion. Whether on the wood of a pier, the metal of a ship’s hull, rocks, or to their own kind, ...

7 Jan 2011

New Research Report on Nanotechnology in Drug Delivery

Reportlinker.com announces that a new market research report is available in its catalogue: Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential. Summary GBI R...

5 Jan 2011

MIT Researchers Say That New Scientific Research Model Focuses on Biomedicine

MIT Researchers Say That New Scientific Research Model Focuses on Biomedicine

A new model for scientific research known as "convergence" offers the potential for revolutionary advances in biomedicine and other areas of science, according to a white paper issued today by 12 leading MIT researchers.

From Massachusetts Institute of Technology 5 Jan 2011

Scientists Explore Novel Ways to Treat Pancreatic Tumors Using Nanomedicine

A five-year, $16-million grant from the National Cancer Institute will take advantage of specialized expertise developed by scientists at Albert Einstein College of Medicine of Yeshiva University and Montefiore, the Univ...

4 Jan 2011

UMass Scientist Recognized as 2010 Cottrell Scholar for Nanotechnology Research

UMass Scientist Recognized as 2010 Cottrell Scholar for Nanotechnology Research

Jennifer L. Ross, a physicist at the University of Massachusetts Amherst, has been named a 2010 Cottrell Scholar, one of the most prestigious fellowships for early career faculty in the sciences.

From University of Massachusetts Amherst 29 Dec 2010

Purdue Scientists Demonstrate Breath-Analysis Using Nanoparticles

Purdue Scientists Demonstrate Breath-Analysis Using Nanoparticles

Researchers have overcome a fundamental obstacle in developing breath-analysis technology to rapidly diagnose patients by detecting chemical compounds called "biomarkers" in a person's respiration in real time.

29 Dec 2010

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.